Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ECYT

Endocyte (ECYT) Stock Price, News & Analysis

Endocyte logo

About Endocyte Stock (NASDAQ:ECYT)

Advanced Chart

Key Stats

Today's Range
$23.99
$23.99
50-Day Range
N/A
52-Week Range
$2.81
$24.00
Volume
N/A
Average Volume
2.12 million shs
Market Capitalization
$1.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ECYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endocyte and its competitors with MarketBeat's FREE daily newsletter.

ECYT Stock News Headlines

Telix Pharmaceuticals Ltd (TLX)
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

ECYT Stock Analysis - Frequently Asked Questions

Endocyte, Inc. (NASDAQ:ECYT) posted its quarterly earnings results on Wednesday, November, 7th. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.01. The biopharmaceutical company earned $0.09 million during the quarter, compared to analyst estimates of $0.02 million. Endocyte had a negative net margin of 32,296.09% and a negative trailing twelve-month return on equity of 21.19%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Endocyte investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), Netflix (NFLX) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/07/2018
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ECYT
CIK
1235007
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.06 million
Net Margins
-32,296.09%
Pretax Margin
N/A
Return on Equity
-21.19%
Return on Assets
-20.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
45.80
Quick Ratio
45.80

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
28,133.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.99 per share
Price / Book
12.06

Miscellaneous

Outstanding Shares
82,090,000
Free Float
N/A
Market Cap
$1.97 billion
Optionable
Optionable
Beta
-0.01
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ECYT) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners